Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Phase III COMMODORE 1 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched from Ravulizumab

Phillip Scheinberg, Hazza Alzahrani, Alejandro Contento Gonzalo, Martin Höglund, Jin Seok Kim, Jens Panse, Melissa J Rose, Jörg Schubert, Yasutaka Ueda, Eng Soo Yap, Muriel Buri, Nicolo' Compagno, Brittany Gentile, Sasha Sreckovic, Austin G. Kulasekararaj

Blood (2024) 144 (Supplement 1): 4078.

https://doi.org/10.1182/blood-2024-200889

Published: 2024

Journal Articles

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry

Pilar Martínez, MD, Tomás Palanques Pastor, Jose Luiz Lopez Lorenzo, MD, Javier Cornago Navascués, MD, Gabriela Rodriguez-Macías, MD, Isabel Cano, MD, Montserrat Arnan Sangerman, María-Belén Vidriales, MDPhD, Jesús Lorenzo Algarra, Maria Angeles Foncillas, Pilar Herrera Puente, Carmen Botella, Susana Vives, MD, Angela Figuera Alvarez, MD PhD, Laida Cuevas Palomares, Marta Sobas, MDPhD, Alejandro Contento-Gonzalo, MD, Rebeca Cuello, MD, María Elena Amutio Diez, MD, Maria Dunia De Miguel, MD, Begoña Navas, MD, Juan Miguel Bergua Burgues, MD, Teresa Bernal del Castillo, MD PhD, María Carmen Mateos Rodríguez, MD, Erik de Cabo López, MD, Ana Carolina Franco Villegas, MD, Raimundo García-Boyero, MD, Cristian Escolano Escobar, MD, Cristina Seri, MD, Carlos Cervero, MD, Alicia Roldán Pérez, Maria Lourdes Hermosin, MD, Marta Cervera, MD, María Teresa Olave, MD, Paola Sandra Villafuerte Gutierrez, MD, Almudena De Laiglesia, MD, Josefina Serrano, MD, María Josefa Najera Irazu, MD, Jose Luis Piñana Sanchez, Miguel Ángel Sanz, MD, Joaquin Martinez-Lopez, MD, Pau Montesinos, MD PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-138471

Published: 2020

Journal Articles

The Management of Relapsed Hodgkin´s Lymphoma after Haploidentical Stem Cell Transplantation: Donnor Lymphocyte Infusion and Brentuximab Vedotin

Alejandro Contento-Gonzalo, MD, Irene Sánchez-Bazán, MD, Daniel Barrios-Decoud, Maria Magdalena Alcalá-Peña, Maria Jesus Pascual-Cascon, Ana Isabel Heiniger, MD

Blood (2017) 130 (Supplement 1): 5502.

https://doi.org/10.1182/blood.V130.Suppl_1.5502.5502

Published: 2017

Journal Articles

Influence of the fusion gene ETV6-RUNX1 in the prognosis of the Pediatric B- Precursor Acute Lymphoblastic Leukemia

Alejandro Contento-Gonzalo, Sr., Antonio Jimenez-Velazco, Sr., Alcala-Peña Magdalena, Manuel Barrios, Sr., Katie Hurst, Dana Diaz-Canales, Soraya Lorente de uña, Jose Coin-Ruiz, Maria Elvira Gonzalez-valentin, Ana Isabel Heiniger Mazo

Blood (2011) 118 (21): 2515.

https://doi.org/10.1182/blood.V118.21.2515.2515

Published: 2011

Journal Articles

Hematopoietic Chimerism LEVELS ARE RELATED to RELAPSE and GRAFT VERSUS Host DISEASE IN REDUCED INTENSITY Allogeneic STEM CELL Transplantion

Alejandro Contento-Gonzalo, Sandra Diaz-Gallardo, Maria Rosario Prieto-Bonilla, Maria Magdalena Alcala-Peña, Jiri Pavlu, Manuel Barrios, Antonio Jimenez-Velazco, Ana Isabel Heiniger Mazo

Blood (2010) 116 (21): 4702.

https://doi.org/10.1182/blood.V116.21.4702.4702

Published: 2010

Journal Articles

Influence of Genetic Variability of GSTM1 and GSTT1 Null Alleles Between Donor and Recipient in the Development of Acute Graft Versus Host Disease.

Alejandro Contento-Gonzalo, Magdalena Alcala-Peña, Manuel Barrios, Macarena Ortiz-Pareja, Antonio Jiménez-Velasco, José Román-Gómez, Antonio P. Torres Gomez, MD, Ana Isabel Heiniger

Blood (2009) 114 (22): 1154.

https://doi.org/10.1182/blood.V114.22.1154.1154

Published: 2009

Journal Articles

Low Levels of Receptor Chimerism, Determined by Real-Time PCR at the Time of Granulocytic Engraftment, Predicts the Onset of Acute Graft Versus Host Disease in Transplanted Leukemic Patients

Alejandro Contento-Gonzalo, Antonio JiménezVelasco, Manuel Barrios, José Román-Gómez, Antonio P. Torres Gomez, MD, Ana Isabel Heiniger

Blood (2008) 112 (11): 4592.

https://doi.org/10.1182/blood.V112.11.4592.4592

Published: 2008

NARROW

Phase III COMMODORE 1 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched from Ravulizumab

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry

The Management of Relapsed Hodgkin´s Lymphoma after Haploidentical Stem Cell Transplantation: Donnor Lymphocyte Infusion and Brentuximab Vedotin

Influence of the fusion gene ETV6-RUNX1 in the prognosis of the Pediatric B- Precursor Acute Lymphoblastic Leukemia

Hematopoietic Chimerism LEVELS ARE RELATED to RELAPSE and GRAFT VERSUS Host DISEASE IN REDUCED INTENSITY Allogeneic STEM CELL Transplantion

Influence of Genetic Variability of GSTM1 and GSTT1 Null Alleles Between Donor and Recipient in the Development of Acute Graft Versus Host Disease.

Low Levels of Receptor Chimerism, Determined by Real-Time PCR at the Time of Granulocytic Engraftment, Predicts the Onset of Acute Graft Versus Host Disease in Transplanted Leukemic Patients

Email alerts

ASH Publications

American Society of Hematology

Phase III COMMODORE 1 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched from Ravulizumab

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry

The Management of Relapsed Hodgkin´s Lymphoma after Haploidentical Stem Cell Transplantation: Donnor Lymphocyte Infusion and Brentuximab Vedotin

Influence of the fusion gene ETV6-RUNX1 in the prognosis of the Pediatric B- Precursor Acute Lymphoblastic Leukemia

Hematopoietic Chimerism LEVELS ARE RELATED to RELAPSE and GRAFT VERSUS Host DISEASE IN REDUCED INTENSITY Allogeneic STEM CELL Transplantion

Influence of Genetic Variability of GSTM1 and GSTT1 Null Alleles Between Donor and Recipient in the Development of Acute Graft Versus Host Disease.

Low Levels of Receptor Chimerism, Determined by Real-Time PCR at the Time of Granulocytic Engraftment, Predicts the Onset of Acute Graft Versus Host Disease in Transplanted Leukemic Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only